Andrew Weiskopf | BioProcess International

Croda Pharma Ask the Expert

Sponsored Content

Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

Building Reliability Into Scale-Up: Targeted Optimization for AAV Production Building Reliability Into Scale-Up: Targeted Optimization for AAV Production

Oct 29, 2024

1 Hr View

Sartorius

Sponsored Content

Sep 17, 2024

40 Min View

Downstream

Recent in Downstream

Saint Gobain Life Sciences filtration

Sponsored Content

Filter Integrity Uncovered: Techniques and Best Practices Filter Integrity Uncovered: Techniques and Best Practices

Bio-Rad Ask the Expert webcast

Dec 3, 2024

30 Min View

Sponsored Content

Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges

Nov 14, 2024

15 Min View

Manufacturing

Recent in Manufacturing

908 Devices Ask the Expert

Sponsored Content

Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality

Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System

Nov 19, 2024

30 Min View

Lonza Ask the Expert

Sponsored Content

Oct 31, 2024

50 Min View

Analytical

Recent in Analytical

ValGenesis Ask the Expert webinar

Sponsored Content

Out of the Box Computer Software Assurance with ValGenesis VLMS Out of the Box Computer Software Assurance with ValGenesis VLMS

Innovative Approaches to Enhance Cell Culture Density for High-Quality Production Innovative Approaches to Enhance Cell Culture Density for High-Quality Production

Nov 7, 2024

30 Min View

Samsung S-Tesify

Sponsored Content

Sep 19, 2024

15 Min View

Business

Recent in Business

Scorpius BioManufacturing Ask the Expert webcast

Sponsored Content

An Innovative Funding Model for Biotech Companies An Innovative Funding Model for Biotech Companies

Lonza Ask the Expert webcast

Dec 10, 2024

7 Min View

Sponsored Content

Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality

Nov 21, 2024

30 Min View

Therapeutic Modalities

Recent in Therapeutic Modalities

Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics

Roche ATE webinar

Sponsored Content

Biomanufacturing in space accelerating therapy development on Earth Biomanufacturing in space accelerating therapy development on Earth

Oct 11, 2024

20 Min View

thumbnail

Bioprocess Insider

byJosh Abbott

Jul 24, 2024

3 Min Read

BioProcess Insider

Recent in BioProcess Insider

Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy Lonza calls time on capsules as mAbs and CGT drive core CDMO strategy

thumbnail

Facilities & Capacity

byDan Stanton

Dec 16, 2024

3 Min Read

Sartorius CGT newsletter

Sponsored Content

Setting the Standard in Cell and Gene Therapy: Perspectives on Performance, Scalability, and Regulatory Compliance Setting the Standard in Cell and Gene Therapy: Perspectives on Performance, Scalability, and Regulatory Compliance

Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management

Dec 4, 2024

2 Min Read

Home
Andrew Weiskopf

Andrew Weiskopf

Latest from Andrew Weiskopf

Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management

byZahra Shahrokh, Andrew Weiskopfand 7 more

Apr 16, 2021

Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability

Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability

byZahra Shahrokh, Andrew Weiskopfand 7 more

Mar 9, 2021

All from Andrew Weiskopf

CMC Strategy Forum on Combination Products for Biopharmaceuticals: Emerging Trends in Development, GMPs, and Regulatory Expectations

Mar 20, 2017

bySiddharth J. Advant, PhD, Jee Chungand 6 more

CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview

Apr 12, 2016

+18

byCheryl Scott, Siddharth J. Advant, PhDand 18 more

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™

Sponsored Content

Special Report

From Pipettes to Infusion Pumps: Volume Accuracy in Regulated Industries and Its Critical Impact

Insider News

SK pharmteco secures $1.4bn GLP-1 deal
Dec 19, 2024
|
2 Min Read
MilliporeSigma to acquire Netherlands-based organoid pioneer HUB
Dec 18, 2024
|
2 Min Read
Israeli biomanufacturer Scinai expands into US with CDMO subsidiary
Dec 18, 2024
|
2 Min Read
CGT Catapult and UCL to develop digital twin for CAR-T manufacturing
Dec 17, 2024
|
3 Min Read